GLP-1 Weight Loss in Charleston, SC: What It Costs Today, and Why South Carolina Medicaid Just Stopped Covering It

South Carolina Medicaid's reversal, dated

South Carolina Medicaid removed GLP-1 medications for the obesity and weight-loss indication from its Preferred Drug List effective 12/31/2025, so coverage for weight loss ends essentially January 1, 2026. That is confirmed directly against SC DHHS's own Pharmacy & Therapeutics Committee minutes of Nov. 5, 2025, which state the change was adopted with no changes to coverage for the diabetes indication ¹⁵. Diabetes-indication GLP-1 coverage is unaffected and continues.

Supplementary reporting from Index-Journal and States Newsroom states South Carolina had added the obesity-indication benefit only around November 2024, as the 14th state to do so, before reversing it about 14 months later citing cost pressure, with state officials citing roughly $2.3M in state spending plus $5.5M in federal spending on obesity-indication prescriptions in the prior fiscal year against an original projection of about $3.3M a year combined; those details come from that news report rather than the primary committee record and were not independently re-verified beyond it ¹⁴. Net effect for Charleston: Medicaid enrollees seeking a GLP-1 for weight loss now have no coverage path and must pay cash, through a local clinic or a telehealth provider, or qualify under a diabetes diagnosis.

What GLP-1 care costs in Charleston today

Holy City Med in West Ashley, at 2039 Savannah Highway inside Charleston city limits, publishes a dose-tiered sheet: semaglutide $99/month at 0.25 or 0.5mg, $149 at 1.0 to 1.25mg, $199 at 1.5 to 1.75mg, and $249 at 2.0 to 2.5mg; tirzepatide $149 at 2.5mg rising through $249, $349, $449, and $549 to $649 at 15mg. It requires a $40/month program fee, waived for existing members, plus a $49 initial consult, waived for members, and includes provider follow-ups and monthly B12 injections, with $35 shipping per shipment or free pickup at the clinic (checked Aug 28, 2026) ⁹.

Pearl Medspa Charleston at 601 Meeting St on the downtown peninsula lists semaglutide starting at $225/month and tirzepatide starting at $300/month; this is pearlmedspachs.com, and its Pearl Membership banner is a general spa discount priced separately at $1,000/year or $49.99/month, not GLP-1 pricing ¹⁰. Holy City HC runs an at-home concierge model at a flat $250/month including in-home injection administration, monthly 3D body-composition scans, a wellness supplement stack, and RN-led nutrition support, stating it is located in Charleston without publishing a street address ¹¹. Several other named Charleston providers, including Charleston Healthspan Institute and Shine Medical Spa, publish no prices at all, and call-for-pricing is itself the finding ¹²¹³.

Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 per year. It is not a Charleston-specific rate.

Strong specialists, one narrow documented gap

Unlike most tier-2 markets, Charleston is not specialist-constrained. It is anchored by the Medical University of South Carolina, which has run a dedicated Weight Management Center since 1974 and operates endocrinology clinics inside city limits at the West Ashley Medical Pavilion and Rutledge Tower downtown, plus one just across the North Charleston line ¹⁶¹⁷. That is materially stronger in-person endocrinology infrastructure than most tier-2 metros.

The documented gap is narrower. No active geographic-area HPSA covers Charleston, city or county, for primary care, mental health, or dental health, per HRSA's national HPSA export refreshed Aug 27, 2026. The only current designations touching the city are facility-type HPSAs for Fetter Health Care Network, Inc., a safety-net FQHC at 51 Nassau St, scored 14 for primary care, 21 mental health, and 21 dental, covering a designated population of 154,576; a second FQHC facility HPSA covers St. James Health & Wellness in rural McClellanville outside city limits. Several historical geographic designations, Low Income - Charleston, Low Income - Sea Islands, and Low Income - North Charleston, were withdrawn and are no longer active ⁶⁷⁸. The shortfall is concentrated among low-income and uninsured patients routed through the safety-net system, not a citywide shortage.

So the honest telehealth case in Charleston is convenience and price transparency rather than access of last resort: a full evaluation and a published flat price without finding and comparing local cash sheets. The South Carolina GLP-1 overview covers statewide policy.